OLIVIA CHANG: Open Payments
NPI 1649844085 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 46 payments from 14 companies in 2025. Trend: 2023 $338 · 2024 $2,322 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $288 |
| Novartis Pharmaceuticals Corporation | 10 | $192 |
| Amgen Inc. | 10 | $177 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| SCPHARMACEUTICALS INC. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: LEQVIO, REPATHA, LifeVest, CAMZYOS, FUROSCIX, EVKEEZA, WINREVAIR, JARDIANCE.
Industry payments across CA — which companies pay providers there.
